图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
真核基因表达评论综述™
影响因子: 2.156 5年影响因子: 2.255 SJR: 0.649 SNIP: 0.599 CiteScore™: 3

ISSN 打印: 1045-4403
ISSN 在线: 2162-6502

真核基因表达评论综述™

DOI: 10.1615/CritRevEukarGeneExpr.v7.i1-2.100
pages 179-193

Gene Regulation Associated with Apoptosis

Birgit M. Jehn
University of Massachusetts at Amherst, Department of Veterinary and Animal Sciences and Program of Molecular Biology, Paige Laboratory, Amherst, Massachusetts 01003.
Barbara A. Osborne
University of Massachusetts at Amherst, Department of Veterinary and Animal Sciences and Program of Molecular Biology, Paige Laboratory, Amherst, Massachusetts 01003.

ABSTRACT

Apoptosis, one of the best-studied forms of programmed cell death processes, plays an important role during the development and life-cycle of most multicellular organisms. The mechanisms underlying the initiation and manifestation of apoptotic cell death are the focus of the most recent cell death research. Generally, it is believed that cells are eliminated via a highly ordered and controlled program. This program might consist of the successive activation of unique apoptosis-specific genes, which are solely involved in the regulation of the programmed cell death. However, more and more evidence is accumulating that novel genes are not activated or induced during apoptosis, but rather many well-known genes previously described for their roles in processes such as proliferation and differentiation and belonging, for example, to the protein families of immediate-early genes and transcription factors become activated. The death-specific feature is achieved thereby by the extent, combination, and specific timing of gene expression. The involvement of the three different transcription factors glucocorticoid receptor (GR), nur77, and activator protein 1 (AP-1) in such a scenario is the focus of this review.


Articles with similar content:

Oncogene-lnitiated Aberrant Signaling Engenders the Metastatic Phenotype: Synergistic Transcription Factor Interactions are Targets for Cancer Therapy
Critical Reviews™ in Oncogenesis, Vol.7, 1996, issue 3-4
David T. Denhardt
Myc Protein: Partners and Antagonists
Critical Reviews™ in Oncogenesis, Vol.5, 1994, issue 1
Juha Klefstrom, Kari Alitalo, Tomi P. Makela, Imre Vastrik, Paivi J. Koskinen
Steel Factor and c-kit Protooncogene: Genetic Lessons in Signal Transduction
Critical Reviews™ in Oncogenesis, Vol.5, 1994, issue 2-3
Janna M. Blechman, David Givol, Yosef Yarden, Sima Lev
Siva-1 Promotes K-48 Polyubiquitination of TRAF2 and Inhibits TCR-Mediated Activation of NF-kappaB
Journal of Environmental Pathology, Toxicology and Oncology, Vol.28, 2009, issue 1
Prasad Kanteti, John Barkinge, Radhika Gudi, Sarah Hawkins, Bellur Prabhakar
Targeting the Regulatory Machinery of BIM for Cancer Therapy
Critical Reviews™ in Eukaryotic Gene Expression, Vol.22, 2012, issue 2
Steven Grant, Hisashi Harada